All Outcomes
Home COVID-19 treatment researchEnsovibepEnsovibep (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta


Supplementary Data — Ensovibep for COVID-19: real-time meta analysis of 2 studies

@CovidAnalysis, April 2024, Version 7V7
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Novartis (RCT) 89% 0.11 [0.01-2.27] death 0/301 2/99 Improvement, RR [CI] Treatment Control Novartis (RCT) 87% 0.13 [0.03-0.67] hosp. 2/301 5/99 Novartis (RCT) 78% 0.22 [0.06-0.76] hosp./ER 4/301 6/99 ACTIV-3/TICO Barkauskas (DB RCT) 17% 0.83 [0.51-1.35] death 30/247 35/238 ACTIV-3/TICO Barkauskas (DB RCT) 6% 0.94 [0.78-1.14] no recov. 44/247 48/238 ACTIV-3/TICO Barkauskas (DB RCT) -8% 1.08 [0.77-1.49] no recov. 247 (n) 238 (n) ACTIV-3/TICO Barkauskas (DB RCT) 7% 0.93 [0.78-1.11] no disch. 28/247 34/238 Ensovibep COVID-19 outcomes April 2024 Favors ensovibep Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop